Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab + Radio-chemotherapy in Localized Rectal Cancer
NCT03127007Phase 2Completed
- Sponsor
- Grand Hôpital de Charleroi
- Start
- Apr 2017
- Primary completion
- Feb 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in rectal cancer, sponsored by Grand Hôpital de Charleroi. Started Apr 2017; status: completed.
02
Drugs
atezolizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03127007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03127007.